최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Brain research, v.1381, 2011년, pp.78 - 89
Oh, Y. (Department of Biology, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, Republic of Korea) , Kim, Y.M. , Mouradian, M.M. , Chung, K.C.
Parkinson's disease (PD) manifests from the impairment of motor systems due to the specific loss of dopaminergic neurons and the appearance of intracellular filamentous inclusions called Lewy bodies (LBs). α-Synuclein, a major component of LBs, is known to contribute to the pathoge...
J. Mol. Biol. Alkema 273 993 1997 10.1006/jmbi.1997.1372 MPc2, a new murine homolog of the Drosophila polycomb protein is a member of the mouse polycomb transcriptional repressor complex
J. Biol. Chem. Bennett 274 33855 1999 10.1074/jbc.274.48.33855 Degradation of α-synuclein by proteasome
Mol. Cell. Biol. Bernstein 26 2560 2006 10.1128/MCB.26.7.2560-2569.2006 Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin
Nat. Cell Biol. Carter 9 428 2007 10.1038/ncb1562 C-terminal modifications regulate MDM2 dissociation and nuclear export of p53
J. Biol. Chem. da Costa 275 24065 2000 10.1074/jbc.M002413200 Wild-type but not Parkinson's disease-related ala-53→Thr mutant alpha-synuclein protects neuronal cells from apoptotic stimuli
FEBS Lett. Desterro 417 297 1997 10.1016/S0014-5793(97)01305-7 Ubch9 conjugates SUMO but not ubiquitin
Mol. Cell Desterro 2 233 1998 10.1016/S1097-2765(00)80133-1 SUMO-1 modification of IκBα inhibits NF-κB activation
J. Biol. Chem. Desterro 274 10618 1999 10.1074/jbc.274.15.10618 Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1
J. Biol. Chem. Dorval 281 9919 2006 10.1074/jbc.M510127200 Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and α-synuclein
Science Giasson 290 985 2000 10.1126/science.290.5493.985 Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions
J. Biol. Chem. Gong 272 28198 1997 10.1074/jbc.272.45.28198 Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9
J. Biol. Chem. Hashimoto 277 11465 2002 10.1074/jbc.M111428200 α-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells
J. Biol. Chem. Hodara 279 47746 2004 10.1074/jbc.M408906200 Functional consequences of α-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation
Nature Hoege 419 135 2002 10.1038/nature00991 RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO
J. Biol. Chem. Iwata 276 45320 2001 10.1074/jbc.M103736200 α-Synuclein affects the MAPK pathway and accelerates cell death
Annu. Rev. Biochem. Johnson 73 355 2004 10.1146/annurev.biochem.73.011303.074118 Protein modification by SUMO
J. Biol. Chem. Johnson 272 26799 1997 10.1074/jbc.272.43.26799 Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p
EMBO J. Johnson 16 5509 1997 10.1093/emboj/16.18.5509 The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer
J. Biol. Chem. Junn 277 47870 2002 10.1074/jbc.M203159200 Parkin accumulation in aggresomes due to proteasome impairment
Cell Kagey 113 127 2003 10.1016/S0092-8674(03)00159-4 The polycomb protein Pc2 is a SUMO E3
EMBO J. Kagey 24 108 2005 10.1038/sj.emboj.7600506 Multiple activities contribute to Pc2 E3 function
Am. J. Pathol. Kahle 159 2215 2001 10.1016/S0002-9440(10)63072-6 Selective insolubility of α-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model
Chembiochem Kim 8 1671 2007 10.1002/cbic.200700366 Correlation of amyloid fibril beta-structure with the unfolded state of α-synuclein
Trends Cell Biol. Kopito 10 524 2000 10.1016/S0962-8924(00)01852-3 Aggresomes, inclusion bodies and protein aggregation
J. Neurochem. Lee 76 998 2001 10.1046/j.1471-4159.2001.00149.x Effect of the overexpression of wild-type or mutant α-synuclein on cell susceptibility to insult
Hum. Mol. Genet. Lee 17 906 2008 10.1093/hmg/ddm363 Ubiquitination of α-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death
Proc. Natl Acad. Sci. USA Li 100 259 2003 10.1073/pnas.0235361100 Positive and negative regulation of APP amyloidogenesis by sumoylation
J. Biol. Chem. Lin 278 31043 2003 10.1074/jbc.C300112200 SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4
Mol. Cell. Proteomics Matic 7 132 2008 10.1074/mcp.M700173-MCP200 In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy
Eur. J. Neurosci. McNaught 16 2136 2002 10.1046/j.1460-9568.2002.02301.x Aggresome-related biogenesis of Lewy bodies
J. Biol. Chem. Okochi 275 390 2000 10.1074/jbc.275.1.390 Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein
Biochem. Biophys. Res. Commun. Okuma 254 693 1999 10.1006/bbrc.1998.9995 In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2
Annu. Rev. Neurosci. Olanow 22 123 1999 10.1146/annurev.neuro.22.1.123 Etiology and pathogenesis of Parkinson's disease
J. Biol. Chem. Rodriguez 276 12654 2001 10.1074/jbc.M009476200 SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting
J. Biol. Chem. Saitoh 275 6252 2000 10.1074/jbc.275.9.6252 Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3
J. Biol. Chem. Saitoh 277 4755 2002 10.1074/jbc.M104453200 Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358
J. Biol. Chem. Sampson 276 21664 2001 10.1074/jbc.M100006200 The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification
PLoS Biol. Sandal 6 e6 2008 10.1371/journal.pbio.0060006 Conformational equilibria in monomeric α-synuclein at the single-molecule level
Mol. Cell. Biol. Satijn 17 6076 1997 10.1128/MCB.17.10.6076 Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis
J. Neurosci. Smith 25 5544 2005 10.1523/JNEUROSCI.0482-05.2005 α-Synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells
Nature Spillantini 388 839 1997 10.1038/42166 α-Synuclein in Lewy bodies
Science Steffan 304 100 2004 10.1126/science.1092194 SUMO modification of Huntingtin and Huntington's disease pathology
J. Biol. Chem. Tanaka 279 4625 2004 10.1074/jbc.M310994200 Aggresomes formed by α-synuclein and synphilin-1 are cytoprotective
FEBS Lett. Tofaris 509 22 2001 10.1016/S0014-5793(01)03115-5 α-Synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome
Anal. Biochem. Uchimura 331 204 2004 10.1016/S0003-2697(04)00378-1 Overproduction of eukaryotic SUMO-1- and SUMO-2-conjugated proteins in Escherichia coli
Biochem. J. Wilkinson 428 133 2010 10.1042/BJ20100158 Mechanisms, regulation and consequences of protein SUMOylation
J. Neurochem. Xie 115 188 2010 10.1111/j.1471-4159.2010.06914.x Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease
Transl. Oncol. Yuan 1 129 2008 10.1593/tlo.08133 Proteasome inhibitor MG132 induces apoptosis and inhibits invasion of human malignant pleural mesothelioma cells
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.